Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children

  • Gibson P
  • Powell H
  • Ducharme F
42Citations
Citations of this article
88Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The addition of a long acting beta agonist (LABA) to inhaled corticosteroid (ICS) therapy can improve asthma symptoms and reduce exacerbations. The addition of LABA may also have an ICS-sparing effect and permit a reduction in ICS maintenance dose.

Cite

CITATION STYLE

APA

Gibson, P. G., Powell, H., & Ducharme, F. M. (2005). Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd005076.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free